New York, USA – September 17, 2026 – Creative Bioarray, a leading provider of innovative biotechnology solutions in the field of life science, is dedicated to transforming drug development decisions and accelerate new therapies through iPSC technology. Creative Bioarray works towards a future where our technology improves lives by enabling new therapeutic modalities and devices; faster, more affordable drug discovery and development. Recently, Creative Bioarray is proud to announce the launch of its comprehensive iPSC characterization services which designed to provide researchers with critical tools needed for the validation, assessment, and application of iPSCs in diverse scientific domains including regenerative medicine, disease modeling, drug discovery, and cell therapy.
Characterization of iPSCs is essential for ensuring the safety, efficacy, and reproducibility of research efforts involving stem cell applications. Demand for iPSC-derived cells in drug screening, disease modeling, and regenerative medicine keeps growing, and so does the need to verify a line’s purity and stability before it scales. Creative Bioarray runs a well-documented protocol covering characterization,custom-scale expansion and banking for any iPSC line. Its characterization services encompass a multifaceted approach that includes cell identity verification, pluripotency validation, genomic stability assessment, differentiation potential testing, and rigorous quality control measures.
Creative Bioarray has developed and characterized over 100 iPSC lines from a variety of human clinical samples, including from both normal and diseased tissue. That experience ensures that you will receive the best quality cell line and full information disclosure about its features and expected performance. Every custom cell line provided by Creative Bioarray follows a standardized workflow—spanning from initial screening to cell bank establishment—with qualitative and quantitative checkpoints integrated at every stage.
Creative Bioarray’s iPSC characterization platform supports the full continuum of stem cell research, enabling scientists to achieve high-quality research outcomes. The company’s dedicated team of stem cell specialists works closely with clients to tailor characterization strategies that align with specific research goals, ultimately leading to breakthroughs in cellular therapies and regenerative medicine.
“Our mission is to empower scientists with the tools they need to understand and harness the power of stem cells,” said Hannah Cole, Marketing Director. “With our comprehensive iPSC characterization services, we aim to improve the reliability and efficiency of stem cell research, thereby accelerating advancements in therapeutic applications.”
In addition to providing characterization services, Creative Bioarray also offers custom solutions and sample processing capabilities tailored to meet the requirements of unique research projects.
About Creative Bioarray
Creative Bioarray is a pioneering biotechnology company dedicated to delivering high-quality reagents and services to the life sciences community. With an extensive catalog of products and a commitment to innovation, Creative Bioarray supports research and clinical applications across the globe.
Media ContactCompany Name: Creative BioarrayContact Person: Hannah ColeEmail: Send EmailPhone: 16313868241Address:Shirley, NY 11967, USA City: ShirleyState: New YorkCountry: United StatesWebsite: https://www.creative-bioarray.com/
